Clinical decision rules and D-Dimer in venous thromboembolism: current controversies and future research priorities

Rodger, Marc A.; Le Gal, Gregoire; Wells, Philip; Baglin, Trevor; Aujesky, Drahomir; Righini, Marc; Palareti, Gualtiero; Huisman, Menno; Meyer, Guy (2014). Clinical decision rules and D-Dimer in venous thromboembolism: current controversies and future research priorities. Thrombosis research, 134(4), pp. 763-768. Elsevier 10.1016/j.thromres.2014.07.031

Text 1-s2.0-S0049384814004083-main.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (209kB)

Venous thromboembolism (VTE) is a potentially lethal clinical condition that is suspected in patients with common clinical complaints, in many and varied, clinical care settings. Once VTE is diagnosed, optimal therapeutic management (thrombolysis, IVC filters, type and duration of anticoagulants) and ideal therapeutic management settings (outpatient, critical care) are also controversial. Clinical prediction tools, including clinical decision rules and D-Dimer, have been developed, and some validated, to assist clinical decision making along the diagnostic and therapeutic management paths for VTE. Despite these developments, practice variation is high and there remain many controversies in the use of the clinical prediction tools. In this narrative review, we highlight challenges and controversies in VTE diagnostic and therapeutic management with a focus on clinical decision rules and D-Dimer.

Interest & Impact

Downloads

0 since deposited on 23 Jan 2015
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item